- Home
- PLBY vs DRRX Comparison
PLBY vs DRRX Comparison
Compare PLBY & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- DRRX
- Stock Information
- Founded
- PLBY 1953
- DRRX 1998
- Country
- PLBY United States
- DRRX United States
- Employees
- PLBY N/A
- DRRX N/A
- Industry
- PLBY Recreational Games/Products/Toys
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- PLBY Consumer Discretionary
- DRRX Health Care
- Exchange
- PLBY Nasdaq
- DRRX Nasdaq
- Market Cap
- PLBY 53.2M
- DRRX 44.4M
- IPO Year
- PLBY N/A
- DRRX 2000
- Fundamental
- Price
- PLBY $1.16
- DRRX $1.01
- Analyst Decision
- PLBY Buy
- DRRX Buy
- Analyst Count
- PLBY 2
- DRRX 2
- Target Price
- PLBY $2.35
- DRRX $5.00
- AVG Volume (30 Days)
- PLBY 8.4M
- DRRX 68.2K
- Earning Date
- PLBY 11-12-2024
- DRRX 11-13-2024
- Dividend Yield
- PLBY N/A
- DRRX N/A
- EPS Growth
- PLBY N/A
- DRRX N/A
- EPS
- PLBY N/A
- DRRX N/A
- Revenue
- PLBY $72,188,000.00
- DRRX $8,594,000.00
- Revenue This Year
- PLBY N/A
- DRRX N/A
- Revenue Next Year
- PLBY N/A
- DRRX $3.07
- P/E Ratio
- PLBY N/A
- DRRX N/A
- Revenue Growth
- PLBY N/A
- DRRX N/A
- 52 Week Low
- PLBY $0.44
- DRRX $0.48
- 52 Week High
- PLBY $1.55
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- PLBY 59.27
- DRRX 26.89
- Support Level
- PLBY $0.85
- DRRX $1.27
- Resistance Level
- PLBY $1.14
- DRRX $1.36
- Average True Range (ATR)
- PLBY 0.19
- DRRX 0.11
- MACD
- PLBY -0.00
- DRRX -0.04
- Stochastic Oscillator
- PLBY 53.85
- DRRX 2.62
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .